Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             144 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 0.07a Enoxaparin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia: the pilot randomised controlled NOH-PE study Gris, J.C.
 2011
 127 S3 p. S126-
1 p.
 artikel
2 0.09a Microparticles' effect on apoptosis, angiogenesis and migration in healthy and pathological pregnancies Shomer, E.
 2011
 127 S3 p. S127-
1 p.
 artikel
3 Angiogenesis in gestational vascular complications Yagel, Simcha
 2011
 127 S3 p. S64-S66
3 p.
 artikel
4 Anticoagulant prophylaxis for placenta mediated pregnancy complications Rodger, Marc A.
 2011
 127 S3 p. S76-S80
5 p.
 artikel
5 Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option McLintock, Claire
 2011
 127 S3 p. S56-S60
5 p.
 artikel
6 Antifibrinolytics in women with menorrhagia Philipp, Claire S.
 2011
 127 S3 p. S113-S115
3 p.
 artikel
7 Antiphospholipid syndrome: Unusual clinical presentations Greaves, Mike
 2011
 127 S3 p. S47-S50
4 p.
 artikel
8 0.08a Prevalence and predictors for post-thrombotic syndrome (PTS) three to 16 years after first-time pregnancy related venous thrombosis – a population-based case-control study Wik, H.S.
 2011
 127 S3 p. S127-
1 p.
 artikel
9 APS – controversies in diagnosis and management, critical overview of current guidelines Pengo, Vittorio
 2011
 127 S3 p. S51-S52
2 p.
 artikel
10 0.10a Risk of PPH in women using therapeutic dosage of LMWH during pregnancy and puerperium Knol, H.M.
 2011
 127 S3 p. S127-S128
2 p.
 artikel
11 0.11a Tranexamic acid reduces blood loss in post-partum haemorrhage Ducloy-Bouthors, A.-S.
 2011
 127 S3 p. S128-
1 p.
 artikel
12 Author index 2011
 127 S3 p. S151-S153
3 p.
 artikel
13 0.11b Gynaecological and obstetric bleeding in moderate and severe Von Willebrand Disease de Wee, E.M.
 2011
 127 S3 p. S129-
1 p.
 artikel
14 0.10b Low-molecular-weight heparin for prevention of obstetric complications in carriers of factor V Leiden or PT-G20210A mutation Tormene, D.
 2011
 127 S3 p. S128-
1 p.
 artikel
15 0.07b Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia Kupfermine, M.
 2011
 127 S3 p. S126-
1 p.
 artikel
16 0.09b p45NF-E2 epigenetically represses Gcm1 in trophoblast cells, regulating syncytium formation, placental vascularization and embryonic growth Kashif, M.
 2011
 127 S3 p. S127-
1 p.
 artikel
17 0.08b Reduced sensitivity to activated protein C in the absence of the factor V Leiden polymorphism is a risk factor for pregnancy related venous thrombosis Bergrem, A.
 2011
 127 S3 p. S127-
1 p.
 artikel
18 0.06b Role of protein S and tissue factor pathway inhibitor in the development of APC resistance early in pregnancy Tchaikovski, S.N.
 2011
 127 S3 p. S126-
1 p.
 artikel
19 0.06C Oligoamenorrhea, high weight accrual rate, acanthosis and first trimester hypertriglyceridemia are independent predictors of preeclampsia Hoirisch Clapauch, S.
 2011
 127 S3 p. S126-
1 p.
 artikel
20 Controversies in postpartum contraception: When is it safe to start oral contraceptives after childbirth? Jackson, Emily
 2011
 127 S3 p. S35-S39
5 p.
 artikel
21 Editorial Board 2011
 127 S3 p. ii-
1 p.
 artikel
22 Epidemiology of the contraceptive pill and venous thromboembolism Hannaford, Philip C.
 2011
 127 S3 p. S30-S34
5 p.
 artikel
23 Is placental haemostasis relevant to recurrent implantation failure? Nelson, Scott M.
 2011
 127 S3 p. S93-S95
3 p.
 artikel
24 LMWH have no place in recurrent pregnancy loss: Debate – against the motion Gris, Jean-Christophe R.
 2011
 127 S3 p. S110-S112
3 p.
 artikel
25 Low-molecular-weight heparins have no place in recurrent miscarriage: Debate – For the motion Middeldorp, Saskia
 2011
 127 S3 p. S105-S109
5 p.
 artikel
26 Mechanisms of anti-phospholipid antibody formation and action de Groot, Philip G.
 2011
 127 S3 p. S40-S42
3 p.
 artikel
27 Microparticles and pregnancy complications Aharon, Anat
 2011
 127 S3 p. S67-S71
5 p.
 artikel
28 Murine models of obesity and hormonal therapy Lijnen, H.R.
 2011
 127 S3 p. S17-S20
4 p.
 artikel
29 Neonatal IVH – mechanisms and management Kenet, Gili
 2011
 127 S3 p. S120-S122
3 p.
 artikel
30 New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications Ahmed, Asif
 2011
 127 S3 p. S72-S75
4 p.
 artikel
31 O.03a A microarray study on the effect of four hormone therapy regimens on gene transcription in leucocytes from healthy postmenopausal women Dahm, A.E.A.
 2011
 127 S3 p. S124-
1 p.
 artikel
32 O.05a Antiphospholipid antibodies and the risk of intrauterine fetal death – Results of a case-control study Helgadóttir, L.B.
 2011
 127 S3 p. S125-
1 p.
 artikel
33 O.02a Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism Lindqvist, P.G.
 2011
 127 S3 p. S123-S124
2 p.
 artikel
34 O.01a Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women Grandone, E.
 2011
 127 S3 p. S123-
1 p.
 artikel
35 O.06a Nocturnal variability of coagulation in gestational diabetes Pöyhönen-Alho, M.
 2011
 127 S3 p. S125-S126
2 p.
 artikel
36 O.04a Risk of VTE during combined oral contraceptive use and pregnancy in women with mild thrombophilia van Vlijmen, E.F.W.
 2011
 127 S3 p. S124-
1 p.
 artikel
37 O.01b All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells Falanga, A.
 2011
 127 S3 p. S123-
1 p.
 artikel
38 O.04b Effect of the dose of oral treatment with 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy postmenopausal women: a randomized double-blind placebo-controlled study Gerotziafas, G.
 2011
 127 S3 p. S125-
1 p.
 artikel
39 O.05b Low molecular weight heparin actions on human endometrial angiogenesis Di Simone, N.
 2011
 127 S3 p. S125-
1 p.
 artikel
40 O.02b Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy Hagman, A.
 2011
 127 S3 p. S124-
1 p.
 artikel
41 O.03b SNPS in the SULT1E1 gene and the risk of oral contraceptive-associated venous thrombosis Stegeman, B.H.
 2011
 127 S3 p. S124-
1 p.
 artikel
42 Overview on guidelines and recommendations for generic low-molecular-weight heparins Harenberg, Job
 2011
 127 S3 p. S100-S104
5 p.
 artikel
43 P.78 ABO blood group and pre-eclampsia – A systematic review Alpoim, P.N.
 2011
 127 S3 p. S147-
1 p.
 artikel
44 P.51 Acquired von Willebrand Syndrome in women with monoclonal gammopathies Djunic, I.
 2011
 127 S3 p. S141-
1 p.
 artikel
45 P.46 Anticoagulation management in pregnancy: patients after heart valve replacement surgery Sukhanov, V.
 2011
 127 S3 p. S140-
1 p.
 artikel
46 P.88 Antiphospholipid antibodies and the risk of recurrent stillbirth Simchen, M.J.
 2011
 127 S3 p. S150-
1 p.
 artikel
47 P.70 Antiphospholipid syndrome in Eve; Clinical observations, phenotypes and correlations Lefkou, E.
 2011
 127 S3 p. S146-
1 p.
 artikel
48 P.6 A reduced allele-specific annexin A5 mRNA in placenta and reduced protein levels Markoff, A.
 2011
 127 S3 p. S130-
1 p.
 artikel
49 P.72 Are the coagulation factor XI levels low during the 3rd trimester of normal pregnancy? Vagdatli, E.
 2011
 127 S3 p. S146-
1 p.
 artikel
50 P.57 Assessment of platelet count and platelet indexes in preeclampsia Freitas, L.G.
 2011
 127 S3 p. S143-
1 p.
 artikel
51 P.14 Association between the MTHFR gene polymorphism and increased risk of recurrent miscarriages in first trimester of pregnancy Seremak-Mrozikiewicz, A.
 2011
 127 S3 p. S132-
1 p.
 artikel
52 P.25 Association of adiponectin levels with abdominal obesity in hypertensive women Skoura, M.
 2011
 127 S3 p. S135-
1 p.
 artikel
53 P.52 Associations between anemia and coagulation abnormalities in women with menorrhagia Djukic, S.
 2011
 127 S3 p. S142-
1 p.
 artikel
54 P.60 Budd-Chiari syndrome in pregnant woman with paroxysmal nocturnal hemoglobinuria Freitas, D.
 2011
 127 S3 p. S143-
1 p.
 artikel
55 P.27 Can anticoagulant therapy improve the outcome of pregnancy in thrombophilic women? Kovac, M.
 2011
 127 S3 p. S135-
1 p.
 artikel
56 P.2 Cerebral venous thrombosis risk factors Kostal, M.
 2011
 127 S3 p. S129-
1 p.
 artikel
57 P.77 Changes in haemostatic parameters induced by drospirenone-containing oral contraceptives Tchaikovski, S.N.
 2011
 127 S3 p. S147-
1 p.
 artikel
58 P.21 Coagulation activation in amniotic fluid during normal human pregnancy Sarig, G.
 2011
 127 S3 p. S134-
1 p.
 artikel
59 P.65 D-dimer as a tool for taking a decision about thromboprophylaxis in a patient with breast cancer Rothschild, C.
 2011
 127 S3 p. S144-S145
2 p.
 artikel
60 P.74 D-dimers in pregnant women with proximal venous thromboses Hagman, A.
 2011
 127 S3 p. S147-
1 p.
 artikel
61 P.39 Decreased fibrin clot porosity in patients with antiphospholipid syndrome Vikerfors, A.
 2011
 127 S3 p. S138-
1 p.
 artikel
62 P.20 Delayed heparin-induced thrombocytopenia in pregnant patient with APIA: diagnosis and treatment Kozak, N.
 2011
 127 S3 p. S134-
1 p.
 artikel
63 P.80 Development of an e-learning tool and patient card to improve pregnancy and contraceptive care of women with prosthetic heart valves Atha, J.
 2011
 127 S3 p. S148-
1 p.
 artikel
64 P.61 Dynamic of the B-1a B cells population throughout normal pregnancy and their possible implication on the onset of preeclampsia Jensen, F.
 2011
 127 S3 p. S144-
1 p.
 artikel
65 P.36 Effect of LMWH prophylaxis on thrombin generation post-caesarean section Ismail, S.K.
 2011
 127 S3 p. S137-S138
2 p.
 artikel
66 P.50 Effect of low dose LMWH “in vitro” addition on thrombin generation potential in healthy pregnant and non pregnant women Rossetto, V.
 2011
 127 S3 p. S141-
1 p.
 artikel
67 P.41 Endogenous thrombin generation (ETP) in anticoagulated women Skoura, M.
 2011
 127 S3 p. S139-
1 p.
 artikel
68 P.40 Endogenous thrombin potential (ETP) in a healthy female population Theodoridis, D.
 2011
 127 S3 p. S138-S139
2 p.
 artikel
69 P.42 Endometrial ablation for the management of heavy menstrual bleeding in women with bleeding disorders Huq, F.Y.
 2011
 127 S3 p. S139-
1 p.
 artikel
70 P.10 Epidemiology of hereditary thrombophilia in miscarriage Vorobyeva, N.A.
 2011
 127 S3 p. S131-
1 p.
 artikel
71 P.3 ETP – a sensitive marker of haemostasis in women undergoing in vitro fertilization Westerlund, E.
 2011
 127 S3 p. S129-S130
2 p.
 artikel
72 P.26 Evaluation of risk factors in women with breast carcinoma who developed venous thromboembolism Kovac, Z.
 2011
 127 S3 p. S135-
1 p.
 artikel
73 P.49 Factor VIIa-antithrombin complexes plasma levels in preeclamptic women Spiezia, L.
 2011
 127 S3 p. S141-
1 p.
 artikel
74 P.28 Factor V Leiden, PT-G20210A, MTHFR C677T mutations and the risk of implantation failure in women undergoing assisted reproductive procedures (IVF or ICSI) Tormene, D.
 2011
 127 S3 p. S135-S136
2 p.
 artikel
75 P.44 FV Leiden as risk factor for preterm birth – a population-based nested case-control study Hiltunen, L.
 2011
 127 S3 p. S140-
1 p.
 artikel
76 P.38 Genetic variability of LXRbeta gene might contribute to preeclampsia Mouzat, K.
 2011
 127 S3 p. S138-
1 p.
 artikel
77 P.63 Hematologic features of pregnant women with miscarriage and thrombophilia Kornyushina, E.A.
 2011
 127 S3 p. S144-
1 p.
 artikel
78 P.66 Hereditary hemorrhagic telangiectasia (HHT) in women: 6 case-reports and comments Rothschild, C.
 2011
 127 S3 p. S145-
1 p.
 artikel
79 P.45 High BMI is correlated to increased thrombin generation in women, age 18-65 after venous thromboembolism Sonnevi, K.
 2011
 127 S3 p. S140-
1 p.
 artikel
80 P.68 Hormone related thrombosis in a male presenting idiopathic oligoasthenoteratozoospermia (iOAT) Papadakis, E.
 2011
 127 S3 p. S145-
1 p.
 artikel
81 P.7 How to prepare and support affected women to deal with the medical condition in Iran Karimi, M.
 2011
 127 S3 p. S130-S131
2 p.
 artikel
82 P.85 Inherent and acquired thrombophilia in cancer patient with thrombosis in past history Vorobiev, A.
 2011
 127 S3 p. S149-
1 p.
 artikel
83 Placental pathology in pregnancy complications Huppertz, Berthold
 2011
 127 S3 p. S96-S99
4 p.
 artikel
84 P.29 Low molecular heparins in prophylaxis of recurrent placental abruptions Panfilova, O.
 2011
 127 S3 p. S136-
1 p.
 artikel
85 P.76 Low molecular weight heparin in women with repeated implantation failure Lodigiani, C.
 2011
 127 S3 p. S147-
1 p.
 artikel
86 P.84 Mechanisms of PLT activation in women with different variants of ischemic stroke Goldobin, V.V.
 2011
 127 S3 p. S149-
1 p.
 artikel
87 P.64 Molecular-genetic and biochemical risk indicators of coagulopathic bleeding in pregnant women with severe preeclampsia and its prevention Bikmullina, D.R.
 2011
 127 S3 p. S144-
1 p.
 artikel
88 P.30 Monitoring Anti-Xa activity of tinzaparin and bemiparin [low-molecular-weight-heparins (LMWHs)] at therapeutic dosages during pregnancy Sierra, A.
 2011
 127 S3 p. S136-
1 p.
 artikel
89 P.75 Obstetric complications in women with factor XI deficiency Myers, B.
 2011
 127 S3 p. S147-
1 p.
 artikel
90 P.87 Obstetric risks for homozygous and heterozygous carriers of the factor V Leiden mutation – does anticoagulation make a difference? Simchen, M.J.
 2011
 127 S3 p. S149-S150
2 p.
 artikel
91 P.5 Occurrence of obstetric and thromboembolic complications in family members of women with common inherited thrombophilias Villani, M.
 2011
 127 S3 p. S130-
1 p.
 artikel
92 Postmenopausal hormone therapy and venous thromboembolism Olié, Valérie
 2011
 127 S3 p. S26-S29
4 p.
 artikel
93 Post-partum hemorrhage in women with rare bleeding disorders Peyvandi, Flora
 2011
 127 S3 p. S116-S119
4 p.
 artikel
94 P.15 Patent foramen ovale in pregnant and non-pregnant women Coccheri, S.
 2011
 127 S3 p. S132-S133
2 p.
 artikel
95 P.34 Pathogenetic prophylactic strategy in women with thrombophilia and history of preeclampsia in future pregnancy Bitsadze, V.O.
 2011
 127 S3 p. S137-
1 p.
 artikel
96 P.54 Pathogenetic prophylaxis in women with history of stroke and thrombophilia during pregnancy Makatsaria, A.D.
 2011
 127 S3 p. S142-
1 p.
 artikel
97 P.16 Pathogenetic prophylaxis of recurrent antenatal fetal death and birth defects in parents with genetically determined hyperhomocysteinemia Talalaeva, I.N.
 2011
 127 S3 p. S133-
1 p.
 artikel
98 P.83 PLT hemostasis in women with pathologic tortuosity of brachiocephalic arteries Tuarsheva, S.M.
 2011
 127 S3 p. S148-S149
2 p.
 artikel
99 P.58 Postpartum life-threatening thromboembolic complications in a patient with paroxysmal nocturnal haemoglobinuria: a ‘rescuer’ role for eculizumab? Jochmans, K.
 2011
 127 S3 p. S143-
1 p.
 artikel
100 P.79 Preeclampsia: ABO blood groups and their relationship with FVIII, vWF and ADAMTS13 plasma levels Alpoim, P.N.
 2011
 127 S3 p. S147-S148
2 p.
 artikel
101 P.4 Preeclampsia as a risk factor for postnatal pulmonary embolism Wibaut, B.
 2011
 127 S3 p. S130-
1 p.
 artikel
102 P.82 Prevention of recurrent thromboembolic complications in women with thrombophilia Akinshina, S.V.
 2011
 127 S3 p. S148-
1 p.
 artikel
103 P.55 Primary coagulopathic massive obstetrical haemorrhage Makatsaria, A.D.
 2011
 127 S3 p. S142-
1 p.
 artikel
104 P.48 Procoagulant phospholipids clotting time in normal pregnancy and preeclampsia Spiezia, L.
 2011
 127 S3 p. S141-
1 p.
 artikel
105 P.23 Prophylaxis with low-dose low-molecular-weight-heparin during pregnancy and postpartum: is it effective? Roeters van Lennep, J.E.
 2011
 127 S3 p. S134-
1 p.
 artikel
106 P.71 Recurrent miscarriage and gestational vascular complications; one year experience from a haematology-obstetric joint clinic Lefkou, E.
 2011
 127 S3 p. S146-
1 p.
 artikel
107 P.62 Renal thrombotic microangiopathy (TMA) in Sneddon's Syndrome (SS) Kirsanova, T.
 2011
 127 S3 p. S144-
1 p.
 artikel
108 P.24 Resistin levels in hypertensive women with impaired renal function Christou, A.
 2011
 127 S3 p. S134-S135
2 p.
 artikel
109 Prevention of VTE in women with cancer Cohen, Alexander T.
 2011
 127 S3 p. S5-S8
4 p.
 artikel
110 P.81 Risk of recurrence after contraception-related venous thrombosis: cohort study Le Moigne, E.
 2011
 127 S3 p. S148-
1 p.
 artikel
111 P.19 Sensitivity to subcutaneous and intravenous unfractionated heparin (UFH) at delivery Rey, E.
 2011
 127 S3 p. S133-
1 p.
 artikel
112 P.33 Study of variability in the management of thromboembolic disease (TD) in women in Spain: national multicenter study Santamaría, A.
 2011
 127 S3 p. S137-
1 p.
 artikel
113 P.18 Switching from LMWH to unfractionated heparin (UFH) during pregnancy: what dose? Rey, E.
 2011
 127 S3 p. S133-
1 p.
 artikel
114 P.12 The cardiovascular continuum in females with insulin resistance: a mechanistic proposal Hoirisch Clapauch, S.
 2011
 127 S3 p. S132-
1 p.
 artikel
115 P.9 The hemostatic system with medical abortion Vorobyeva, N.A.
 2011
 127 S3 p. S131-
1 p.
 artikel
116 P.8 The pregnancy outcome in patients with minor β-thalassemia Amooee, S.
 2011
 127 S3 p. S131-
1 p.
 artikel
117 P.59 Therapeutic versus prophylactic low molecular weight heparin regimen during pregnancy: the incidence of treatment complications Mitic, G.
 2011
 127 S3 p. S143-
1 p.
 artikel
118 P.86 The role of tissue factor and tissue factor pathway inhibitor in ovarian cancer Abu Saadeh, F.
 2011
 127 S3 p. S149-
1 p.
 artikel
119 P.47 The structure of occult haemostasis system disorders in women with the history of massive obstetrical haemorrhage Smurygina, V.V.
 2011
 127 S3 p. S140-S141
2 p.
 artikel
120 P.32 The TEAM project: Spanish Registry of Thromboembolic Disease (TD) related with hormonal treatments, pregnancy, obstetrics complications or assisted reproductive procedures in women (ARP) Santamaría, A.
 2011
 127 S3 p. S136-S137
2 p.
 artikel
121 P.37 The use of low-molecular-weight heparin nadroparin calcium by pregnant women with thrombophilia Hulikova, M.
 2011
 127 S3 p. S138-
1 p.
 artikel
122 P.43 Thrombin activatable fibrinolysis inhibitor (TAFI) antigen and activity levels in normal pregnancy Huq, F.Y.
 2011
 127 S3 p. S139-S140
2 p.
 artikel
123 P.73 Thrombin generation test in pregnancy Procházka, M.
 2011
 127 S3 p. S146-
1 p.
 artikel
124 P.17 Thrombophilia and complications of multiple pregnancy after IVF Makatsaria, N.
 2011
 127 S3 p. S133-
1 p.
 artikel
125 P.1 Thromboprophylaxis in pregnancy in women with increased risk of venous thromboembolism Dulííck, P.
 2011
 127 S3 p. S129-
1 p.
 artikel
126 P.56 Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) plasma levels in severe reeclampsia Godoi, L.C.
 2011
 127 S3 p. S142-S143
2 p.
 artikel
127 P.67 Type and location of thromboembolism in females carrying FV Leiden mutation during pregnancy/puerperium or oral contraceptive/hormone replacement therapy: experience from a single center Spyrou, A.
 2011
 127 S3 p. S145-
1 p.
 artikel
128 P.35 Unclear clinical case of multiple recurrent thrombosis in pregnancy Bitsadze, V.O.
 2011
 127 S3 p. S137-
1 p.
 artikel
129 P.53 Use of low molecular-weight heparin and natural progesterone for the prevention of recurrent pregnancy complications (pre-eclampsia, pregnancy loss, placental abruption) in women with metabolic syndrome Radulovich, T.B.
 2011
 127 S3 p. S142-
1 p.
 artikel
130 P.31 Venous thromboembolism and Mirena – case report Kozak, M.
 2011
 127 S3 p. S136-
1 p.
 artikel
131 P.22 Venous thromboembolism in women after transfusion Rogers, M.A.M.
 2011
 127 S3 p. S134-
1 p.
 artikel
132 P.69 Venous thromboembolism in women; One year experience from a thrombophilia clinic Lefkou, E.
 2011
 127 S3 p. S145-
1 p.
 artikel
133 P.13 Walking and metformin to improve perinatal outcomes Hoirisch Clapauch, S.
 2011
 127 S3 p. S132-
1 p.
 artikel
134 P.11 Weight-adjusted dosing of tinzaparin in pregnancy Gibson, P.S.
 2011
 127 S3 p. S131-S132
2 p.
 artikel
135 Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis Décousus, Hervé
 2011
 127 S3 p. S81-S85
5 p.
 artikel
136 Resistance to anti-platelet agents Cattaneo, Marco
 2011
 127 S3 p. S61-S63
3 p.
 artikel
137 Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation Girardi, Guillermina
 2011
 127 S3 p. S43-S46
4 p.
 artikel
138 The diagnostic management of acute venous thromboembolism during pregnancy: recent advancements and unresolved issues Tan, M.
 2011
 127 S3 p. S13-S16
4 p.
 artikel
139 The post thrombotic syndrome Kahn, Susan R.
 2011
 127 S3 p. S89-S92
4 p.
 artikel
140 Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry Trujillo-Santos, Javier
 2011
 127 S3 p. S1-S4
4 p.
 artikel
141 Thrombin generation tests Castoldi, Elisabetta
 2011
 127 S3 p. S21-S25
5 p.
 artikel
142 Thromboprophylaxis after cesarean section: decision analysis Blondon, Marc
 2011
 127 S3 p. S9-S12
4 p.
 artikel
143 Vascular complications in diabetic pregnancy Kaaja, R.
 2011
 127 S3 p. S53-S55
3 p.
 artikel
144 Venous thrombosis at unusual site in women Romualdi, Erica
 2011
 127 S3 p. S86-S88
3 p.
 artikel
                             144 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland